Skip to content
Alpha Edge Investing

Alpha Edge Investing

"Investors operate with limited funds and limited intelligence, they don’t need to know everything. As long as they understand better than others, they have an edge.” – George Soros

  • Home
  • Earnings Updates/ Corporate Actions
  • Research – Equities
  • Research – Fixed Income/ Bonds
  • Research – Unit Trust/ ETF
  • News
  • My Opinions/ Views
  • Others
  • About Me
  • Contact
  • Disclaimer
  • Community and Support Forums
  • Toggle search form

OIR: Genting Singapore – Buy Fair Value $0.92 (Previous $0.90)

Posted on July 26, 2022July 26, 2022 By alanyeo No Comments on OIR: Genting Singapore – Buy Fair Value $0.92 (Previous $0.90)

Recovery underway

  • Recovery gains momentum post Singapore’s full reopening
  • RWS 2.0 construction commenced in 2Q22
  • Positive reading from Marina Bay Sands’ 2Q22 performance
Visitor arrivals to Singapore recovered to 35% of pre-Covid levels in Jun 2022

Following the easing of travel restrictions in Singapore, visitor arrival improved significantly by 143%, 42% and 30% MoM in Apr, May and Jun 2022 respectively, reaching 35% of its pre-Covid levels. There was particularly strong growth of visitor arrivals from Indonesia, India, Malaysia and Australia (36% of pre-Covid arrivals into Singapore). While China’s reopening of boarder remains uncertain (19% of pre-Covid tourists’ arrivals to Singapore), the shortfall could be partially replaced by visitors from other source markets due to strong pent-up demand, aiding the recovery of GENS.

Encouraging MBS’ 2Q22 results

Las Vegas Sands reported its 2Q22 results which showed encouraging recovery at MBS during the quarter, driven by Singapore’s full reopening. MBS saw strong growth across both gaming and nongaming segments. Adjusted property EBITDA grew 164% quarter-on-quarter (QoQ) to USD319m (185% year-on-year, YoY) in 2Q22, which was the best performing quarter since the onset of the
pandemic. We see MBS’ results as a positive to GENS which could suggest a faster-than-expected
recovery in 2Q22 following Singapore’s reopening in April 2022.

RWS 2.0 is targeted to open in 4Q24

GENS had commenced constructions works on both Minion Land and the Singapore Oceanarium in 2Q22. Targeted opening date is by end of 2024. As of 31 Dec 2021, GENS had net cash of SGD3.1b and is in healthy financial position to fulfil its commitment of RWS 2.0. Management also mentioned that they
are likely to review its dividend policy to reward shareholders. We expect a full year dividend of 2 Singapore cents per share in 2022. As countries reopen borders and ease travel restrictions, we expect better quarters ahead for GENS, barring the risks of a spike in Covid-19 cases and a recession. We revise our estimates to incorporate a faster recovery but higher operating costs. Our fair value estimate hence increases from SGD0.90 to SGD0.92.

ESG Updates

GENS lags its global peers on governance. GENS has related party transactions with the controlling
shareholder, Genting Overseas Holdings Limited (52.8% votes held). GENS demonstrates initiatives to
mitigate the effects of problem gambling such as advertisements, self-exclusion and voluntary visit
limit options. However, unlike better-performing peers, there is no evidence of play safe limits such
as voluntary money and time limit settings. BUY. (Chu Peng)

2022-07-25_GENS-SP-OIRClick here to Download Full Report in PDF

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Telegram (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
Research - Equities Tags:Genting SP

Post navigation

Previous Post: OIR: SATS Ltd – Buy Fair Value $4.72 (Previous $4.94)
Next Post: OIR: Singapore Residential Sector

Related Posts

UOBKH: Gaming Singapore (Overweight) Research - Equities
UOBKH: Singapore Monthly Review and Outlook Research - Equities
UOBKH: STRATEGY – SINGAPORE Research - Equities
KGI: Genting Singapore (GENS SP) – “Rooms” are hot Research - Equities
DBS: Singapore Equity Picks – Guarding our performance 19 Sep 2022 Research - Equities
UOBKH: Singapore Strategy Research - Equities
OIR: Genting SP – Buy Target Price $0.92 Research - Equities
DBS: Genting Singapore – Buy Target Price $1.00 Research - Equities
UOBKH: Genting Singapore – Buy Target Price $1.08 Research - Equities
CIMB: Genting Singapore – Add Target Price $1.04 Research - Equities
UOBKH: Monthly Review and Outlook – Singapore Research - Equities
UOBKH: Singapore Strategy – Alpha Picks Research - Equities

Leave a Reply

You must be logged in to post a comment.

Login

Log In
Register Lost Password
Get new posts by email
Chat on WhatsApp
  • Earnings Updates/ Corporate Actions
  • My Opinions/ Views
  • News
  • Others
  • Research – Equities
  • Research – Fixed Income/ Bonds
  • Research – Unit Trusts/ ETF

Copyright © 2023 Alpha Edge Investing.

Powered by PressBook Grid Blogs theme